Reports
Reports
Sale
The value of the global medical biomimetics market was USD 37.11 billion in 2023, driven by the increasing demand for innovative medical products and technologies across the globe. The market value is anticipated to grow at a CAGR of 6.9% during the forecast period of 2024-2032 to reach a value of 67.37 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to be a major market for medical biomimetics due to trends such as an increase in the rate of adoption of novel technologies, growth in geriatric population, an increase in research and development activities related to medical biomimetics, and a strong presence of key players. Meanwhile, the market in the Asia Pacific is expected to expand at a high growth rate during the forecast period due to factors including an increase in government initiatives in the healthcare sector, the increase in the medical tourism sector, and a booming biotechnology industry.
Biomimetics is an interdisciplinary discipline that incorporates the concepts of chemistry, engineering, and biology. The principles of biomimetics are applicable to the synthesis of materials, devices, or synthetic structures consisting of functions or operations that imitate biological processes. Biomimetic designs are used for tissue engineering, regenerative medicine, and drug delivery.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product types, the industry can be divided as follows:
The product finds wide applications in the following segments:
The regional markets for medical biomimetics can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The demand for medical biomimetics is expected to grow at a rapid rate in the coming years. A sharp rise in the geriatric population, an increase in the rate of organ failure, an increase in the adoption of biomimetic technologies for organ regeneration, an increase in applications for tissue engineering, an increase in research and development activities, and developments in nanotechnology are expected to fuel the sector. Nanotechnology has the ability to explain single molecules/cells at a very high performance and demonstrates complex biomimetic behaviour. Such developments can result in the development of personalised medicine. Nanoparticles can exhibit progressive functions, including stimulus response, cell/organ targeting, imaging, and drug delivery. Such beneficial capacities, along with continuous developments, would have a positive effect on the growth of the biomimetic industry in the coming years.
The report gives a detailed analysis of the following key players in the global medical biomimetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Medical Biomimetics Market Overview
3.1 Global Medical Biomimetics Market Historical Value (2017-2023)
3.2 Global Medical Biomimetics Market Forecast Value (2024-2032)
4 Global Medical Biomimetics Market Landscape
4.1 Global Medical Biomimetics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Medical Biomimetics Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Medical Biomimetics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Medical Biomimetics Market Segmentation
6.1 Global Medical Biomimetics Market by Product Type
6.1.1 Market Overview
6.1.2 Cardiovascular
6.1.3 Orthopedic
6.1.4 Ophthalmology
6.1.5 Dental
6.1.6 Others
6.2 Global Medical Biomimetics Market by Application
6.2.1 Market Overview
6.2.2 Plastic Surgery
6.2.3 Wound Healing
6.2.4 Tissue Engineering
6.2.5 Others
6.3 Global Medical Biomimetics Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Medical Biomimetics Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Medical Biomimetics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Medical Biomimetics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Medical Biomimetics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Medical Biomimetics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Medical Biomimetics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Blatchford Limited
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Vandstrom, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Veryan Medical Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 OTSUKA MEDICAL DEVICES GROUP
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 STRYKER
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 ABBOTT
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 AVINENT SCIENCE AND TECHNOLOGY
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 SYNTOUCH INC
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 OSTEOPORE INTERNATIONAL PTE LTD
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BIOMIMETICS TECHNOLOGIES INC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 KEYSTONE DENTAL GROUP
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 CORNEAT VISION
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 NANOHIVE MEDICAL LLC
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Medical Biomimetics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market is projected to grow at a CAGR of 6.9% between 2024 and 2032.
The development of the industry is being driven by factors like increasing disposable income, rising geriatric population, increasing rate of organ failure, rising adoption of biomimetic technologies for organ regeneration, and increase in research and development activities.
The rising development in nanotechnology is an important trend boosting the industry growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading product types of medical biomimetics in the market are cardiovascular, orthopaedic, ophthalmology, and dental, among others.
The major application segments in the industry are plastic surgery, wound healing, and tissue engineering, among others.
The major players in the industry are Blatchford Limited, Vandstrom, Inc., and Veryan Medical Limited, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.